BLOG / 🇮🇳 India / index intelligence · · daily

BSE FMCG Sector Regulatory Filings — November 05, 2026

India BSE FMCG

By Gunpowder Editorial ·

6 high priority 12 medium priority 18 total filings analysed

Executive Summary

The 18 filings cover S&P BSE FMCG constituents dated 2026-11-05, dominated by Q2 FY27 results cycles from Emami, Dabur, Britannia, United Spirits and Marico, plus Varun Beverages.

Headline top-line growth was strong: Emami consolidated revenue rose 36.2% YoY to ₹1,08,765 Lacs (helped by Axiom Ayurveda and IncNut Digital acquisitions), Britannia consolidated revenue rose roughly 15.6% YoY to ₹5,597.79 Crore with 13% volume growth, and Dabur consolidated revenue grew 11.6% with India FMCG up 10.7% on 5.5% volume growth. Profitability lagged the top line across the sector: Emami consolidated PAT fell 1.9% YoY and standalone PAT fell about 25%, with gross margin down 520 bps to 65.8% and EBITDA margin down 200 bps to 20.4%; Dabur operating margin contracted 60 bps amid elevated input costs and inflation. Britannia's standalone PBT grew only about 4.5% and its current borrowings jumped to ₹2,439.52 Crore from ₹1,071.72 Crore with inventories up sharply, a working-capital and leverage watch item. Capital returns remained generous (Emami ₹5/share interim dividend plus a ₹281.24 Cr buyback; Britannia ₹2,172.22 Crore dividends paid in six months), and the key pending catalysts are the 13 Nov 2026 Emami record date and a cluster of 16–17 Nov investor conferences. Filing-level governance items (qualified auditor review at Emami, DRI seizure at United Spirits) add event risk to an otherwise constructive but margin-pressured sector setup.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Corporate governance · Corporate action

Tracking the trend? Catch up on the prior BSE FMCG Sector Regulatory Filings digest from November 04, 2026.

Investment Signals (11)

  • ▲

    Consolidated revenue up 36.2% YoY to ₹1,08,765 Lacs and H1 revenue up 24.9% YoY; domestic business grew 49% on 43% volume growth, with Quick Commerce at ~15% of digital sales

  • ▲

    Consolidated PAT down 1.9% YoY to ₹14,550 Lacs and standalone PAT down ~25% YoY, with gross margin compressed 520 bps to 65.8% and EBITDA margin down 200 bps to 20.4%

  • Consolidated revenue up ~15.6% YoY to ₹5,597.79 Crore and consolidated PAT up 10.8%; Q2 sales of ₹5,542 Crore grew 16.6% on 13% volume growth, with sequential growth of 12% top-line and 22% bottom-line

  • Standalone PBT grew only ~4.5% YoY and other income fell 34.5% as the prior-year quarter included ₹58.94 Crore of subsidiary dividends, so underlying operating momentum is weaker than headline profit growth

  • Current borrowings rose to ₹2,439.52 Crore from ₹1,071.72 Crore and inventories to ₹2,322.67 Crore from ₹1,345.93 Crore since 31 March 2026, while cash fell to ₹190.75 Crore; ₹2,172.22 Crore of dividends paid in six months

  • ▲

    Consolidated revenue grew 11.6% and PAT grew 11.7%, with India FMCG revenue up 10.7% on 5.5% volume growth and International up 20.0% to ₹1,091 Cr

  • ▲

    Operating profit grew only 7.5% with a 60 bps margin decline, and Healthcare grew just 6.9%, signalling input-cost pressure despite top-line momentum

  • ▲

    Interim dividend of ₹5 per share (500% of face value) with record date 13 Nov 2026 and payment by 4 Dec 2026, plus completion of a ₹281.24 Cr buyback (73,00,000 shares)

  • ▲

    Management attending CITIC CLSA, JM Financial and Avendus conferences on 16–17 Nov 2026 with no UPSI to be shared; no financial data disclosed, so limited signal content

  • ▲

    DRI seizure of goods worth ~INR 6.45 crore under the India–UK FTA classification issue, with management reporting no material business impact yet and expecting early resolution

  • Marico ↓ (NEUTRAL)
    ▲

    Routine conference attendance on 16–17 Nov 2026 with no financial data disclosed; monitor for qualitative commentary on demand and input costs

Risk Flags (9)

  • Auditor's review report on Q2 FY27 results is qualified because a subsidiary contributing ₹8,357 Lacs revenue and ₹941 Lacs net profit was not reviewed, plus a share of associate net loss of ₹34 Lacs

  • PAT down 3% in Q2 despite 36% revenue growth as tax normalisation and 520 bps gross-margin compression eroded earnings; H1 consolidated PAT down 9.0% YoY to ₹28,444 Lacs

  • ▼

    Three independently reviewed subsidiaries posted a combined H1 net loss of ₹439 lacs and one subsidiary group had a net cash outflow of ₹189 lacs in H1 FY27

  • ▼

    International business revenue fell 2% due to geopolitical disruption, a drag on diversification

  • Current borrowings up ~127% since March 2026 to ₹2,439.52 Crore while inventories rose ~73%, creating short-term debt and cash-conversion pressure alongside ₹2,172.22 Crore of dividends paid

  • Standalone other income fell 34.5% YoY, so reported PAT growth partly reflects weaker underlying standalone operating growth

  • Management flagged ongoing inflationary pressures as a continuing watch item despite 13% volume growth

  • ▼

    Operating margin down 60 bps with gross margins hit by elevated input costs and inflation, while Healthcare segment growth slowed to 6.9%

  • DRI seizure memos for ~INR 6.45 crore of goods under Section 110 of the Customs Act, with the company disclosing the seizure memo announcement late, a governance concern

Opportunities (9)

  • Domestic business up 49% with 43% volume growth and Strategic Investments portfolio rising to ~26% of domestic business from 22% in H1, indicating scalable newer brands

  • Organised channels at 37% of domestic business and Quick Commerce at ~15% of digital sales, with the FromMaa baby-care entry under BoroPlus widening the addressable portfolio

  • ₹5/share interim dividend (record date 13 Nov 2026) plus completed ₹281.24 Cr buyback offers near-term shareholder yield and a catalyst around the record date

  • H1 consolidated sales up 13.1% with volume up 11%, and Bakery/adjacencies plus International showing strong acceleration beyond core biscuits

  • Six-month operating cash flow rose to ₹935.94 Crore from ₹369.87 Crore, suggesting improved cash generation if working-capital build reverses

  • Alternate channels grew at strong double digits, General Trade grew mid-to-high single digits, and Beverages recovered sequentially with mid-teens growth

  • Seven #1 brands by share including Amla, Chyawanprash, Honey and Mosquito Repellant (>50–60% share in each), supporting pricing power when input costs ease

  • International business grew 20.0% to ₹1,091 Cr, the fastest-growing segment and a diversification lever

  • Industry association reports Ministry of Commerce assurance on early resolution of the DRI tariff matter; provisional release of seized goods would remove the overhang

Sector Themes (6)

  • Top-Line Growth vs Margin Squeeze
    ◆

    Four of five reporting FMCG names showed revenue growth of 11–36% YoY, yet profit growth lagged (Emami PAT -1.9%, Dabur operating profit +7.5% with -60 bps margin, Emami gross margin -520 bps), indicating input-cost inflation is absorbing volume-led growth [IMPLICATION: favour companies with pricing power and hedged input costs]

  • Working Capital and Leverage Build
    ◆

    Britannia's current borrowings rose ~127% and inventories ~73% since 31 March 2026, with dividends of ₹2,172.22 Crore paid in H1 — a pattern of shareholder payouts being partly debt-funded that warrants monitoring across the sector [IMPLICATION: track debt and inventory days in upcoming filings]

  • Shareholder Returns Remain Robust
    ◆

    Emami (₹5/share interim plus ₹281 Cr buyback) and Britannia (₹2,172 Cr dividends in six months) show sustained payout commitments even as margins compress [IMPLICATION: yield support in a margin-pressured sector, but payouts must be covered by cash flow]

  • Quick Commerce and Digital Channel Shift
    ◆

    Emami (Quick Commerce ~15% of digital sales, organised channels 37% of domestic) and Dabur (alternate channels growing double digits) both point to channel mix shifting toward modern and digital trade [IMPLICATION: relative winners are brands with strong digital and organised-trade execution]

  • Geopolitical and Regulatory Friction in Exports and Imports
    ◆

    Emami International down 2% on geopolitical disruptions and United Spirits facing DRI seizure over India–UK FTA tariff treatment shows trade-policy exposure is an emerging sector risk [IMPLICATION: export-oriented and FTA-dependent lines carry elevated event risk]

  • Governance and Disclosure Quality
    ◆

    Emami's qualified auditor review over an unreviewed subsidiary and United Spirits' late disclosure of seizure memos point to disclosure-timeliness and audit-scope issues that investors should screen for [IMPLICATION: apply tighter governance screens to names with recent disclosure lapses]

Watch List (7)

  • Interim dividend of ₹5/share with record date 13 Nov 2026 and payment by 4 Dec 2026; watch for auditor qualification resolution and any subsidiary review update

  • Gross margin compressed 520 bps and EBITDA margin down 200 bps in Q2; monitor input-cost trends and tax-rate normalisation in Q3 commentary

  • Current borrowings of ₹2,439.52 Crore and inventories of ₹2,322.67 Crore; watch for inventory unwind and debt reduction in the next filing

  • Operating margin down 60 bps and Healthcare growth at 6.9%; track gross-margin recovery and Healthcare segment acceleration

  • Seized goods (~INR 6.45 crore) pending provisional release under Section 110 of the Customs Act; a resolution or escalation would be a material event

  • Investor Conference Cluster (16–17 Nov 2026)
    👁

    Varun Beverages (CITIC CLSA, JM Financial, Avendus), Marico (Avendus One-on-One 16 Nov, JM Financial Group 17 Nov) and Dabur (CITIC CLSA 17 Nov, Mumbai) — monitor qualitative guidance commentary despite no UPSI disclosure

  • Newly appointed Company Secretary Debendra Banthiya (effective 5 Nov 2026) and KMP authorisation under Reg 30(5); routine but relevant to disclosure-timeliness scrutiny

Filing Analyses (18)
Emami Limited Corporate Governance mixed materiality 9/10

05-11-2026

Emami Limited reported consolidated revenue from operations of ₹1,08,765 Lacs for Q2 FY27, up 36.2% YoY from ₹79,851 Lacs, driven by strong domestic growth and contributions from recent acquisitions (Axiom Ayurveda and IncNut Digital). However, consolidated PAT declined 1.9% YoY to ₹14,550 Lacs, and standalone PAT fell 25.2% YoY to ₹13,646 Lacs, impacted by higher tax expenses and a one-time buyback. The Board declared an interim dividend of 500% (₹5 per share).

  • · Consolidated total income for Q2 FY27 was ₹1,11,060 Lacs, up from ₹81,988 Lacs YoY.
  • · Consolidated half-year PAT (H1 FY27) was ₹28,444 Lacs, down 9.0% from ₹31,261 Lacs in H1 FY26.
  • · Standalone half-year PAT (H1 FY27) was ₹31,868 Lacs, down 7.7% from ₹34,543 Lacs in H1 FY26.
  • · Consolidated total comprehensive income for Q2 FY27 was ₹17,125 Lacs, up 17.6% YoY from ₹14,562 Lacs.
  • · Standalone total comprehensive income for Q2 FY27 was ₹16,371 Lacs, down 8.0% from ₹17,787 Lacs YoY.
  • · The auditor's report includes a qualified conclusion due to unreviewed financials of one subsidiary (including its two subsidiaries) for the quarter.
  • · The buyback of 73,00,000 equity shares was completed on October 9, 2026, at a total cost of ₹28,124 Lacs.
  • · The company recorded a financial liability of ₹21,930 Lacs towards the second tranche of the Axiom acquisition and ₹20,490 Lacs for the IncNut acquisition.
  • · Consolidated net cash outflow from financing activities was ₹31,792 Lacs for H1 FY27, driven by buyback and debt repayment.
  • · Standalone cash and cash equivalents fell to ₹682 Lacs as of Sep 30, 2026, from ₹13,405 Lacs as of Mar 31, 2026.
Emami Limited Market Notice mixed materiality 9/10

05-11-2026

Emami Limited reported robust Q2FY27 results with consolidated revenue growing 36% to ₹1,088 crore and domestic business surging 49% (volume growth 43%). However, PAT declined 3% to ₹144 crore due to tax rate normalization, and international business revenue fell 2% due to geopolitical disruptions. The Board approved an interim dividend of ₹5 per share and completed a ₹281.24 crore share buyback.

  • · COGS increased 520 bps to 34.2% of revenue in Q2FY27, indicating input cost pressure.
  • · Gross margins declined 520 bps to 65.8% in Q2FY27.
  • · EBITDA margins declined 200 bps to 20.4% in Q2FY27.
  • · PBT margins declined 100 bps to 17.8% in Q2FY27.
  • · PAT margins declined 530 bps to 13.3% in Q2FY27.
  • · Hair & Scalp Care net sales ₹194 Cr (22% of domestic business) grew 30% YoY.
  • · Skin Care net sales ₹191 Cr (21% of domestic business) grew 31% YoY.
  • · Health Care net sales ₹284 Cr (31% of domestic business) grew 11% YoY.
  • · Strategic Investments net sales ₹239 Cr (26% of domestic business) grew 73% like-to-like YoY.
  • · International Business net sales ₹171 Cr (16% of consolidated) declined 2% YoY.
  • · Organised channels contributed 37% of domestic business; Quick Commerce ~15% of digital sales.
  • · BoroPlus grew in near twenties; Talc & Prickly Heat powder sales more than doubled.
  • · Navratna Cool Oils grew in thirties; Kesh King posted high teens growth; 7 Oils in One nearly doubled.
  • · Pain Management grew in teens; Zandu Healthcare posted high single digit growth.
  • · The Man Company reported 3.9x like-to-like sales growth in Q2FY27.
  • · Brillare reported 3.8x like-to-like sales growth in H1FY27.
  • · International Business underlying growth excluding Nepal & Iraq was +6% in Q2FY27.
  • · H1FY27: Domestic business reported +33% (like-to-like +21%, volume +28% reported, +17% like-to-like).
  • · H1FY27: International Business reported -7% YoY.
  • · H1FY27: Hair & Scalp Care +18%, Skin Care +14%, Health Care +7%, Strategic Investments +68% like-to-like.
Emami Limited Market Notice mixed materiality 9/10

05-11-2026

Emami Limited reported a robust Q2FY27 with consolidated revenue from operations growing 36% to ₹1,088 crore, driven by a 49% surge in domestic business (43% volume growth). However, profitability was mixed: while EBITDA grew 25% to ₹222 crore and PBT grew 29% to ₹194 crore, PAT declined 3% to ₹144 crore due to the normalization of the effective tax rate. The International Business declined 2% due to geopolitical disruptions, and input costs remained elevated, causing gross margins to contract by 520 bps.

  • · Strategic Investments portfolio contributed ~26% of domestic business in Q2FY27, up from 22% in H1FY27.
  • · Organised channels contributed 37% of domestic business and Quick Commerce accounted for ~15% of total digital sales.
  • · The company entered the baby care category with the 'FromMaa' range under the BoroPlus brand.
  • · International Business declined 2% reported, but grew 6% excluding Nepal and Iraq.
  • · COGS was 34.2% of revenue, 520 bps higher YoY in Q2FY27.
  • · EBITDA margins contracted 200 bps YoY to 20.4% in Q2FY27.
  • · PAT margins contracted 530 bps YoY to 13.3% in Q2FY27.
  • · H1FY27 consolidated revenues stood at ₹2,127 crore, up 25% YoY.
  • · H1FY27 EBITDA was ₹449 crore, up 14% YoY.
  • · H1FY27 PBT was ₹388 crore, up 15% YoY.
  • · International Business contributed 14% to consolidated business in H1FY27.
  • · The company's products reach over 5.4 million retail outlets in India.
Emami Limited Corporate Action positive materiality 8/10

05-11-2026

Emami Limited's Board approved unaudited consolidated financial results for Q2 and H1 FY27, showing strong revenue growth of 36.2% YoY to ₹1,08,765 Lacs for the quarter and 24.9% YoY to ₹2,12,686 Lacs for the half year. The Board also declared a first interim dividend of ₹5 per share (500% on face value of Re. 1) for FY27, with a record date of November 13, 2026. However, the auditor's review report carries a qualified conclusion due to one unreviewed subsidiary (including its two subsidiaries) contributing ₹8,357 Lacs in revenues and ₹941 Lacs in net profit for the quarter, and the company's share of net loss from associates was ₹34 Lacs for the quarter.

  • · The Board meeting commenced at 12:00 Noon and concluded at 1:35 P.M. on November 5, 2026.
  • · Record date for interim dividend is Friday, November 13, 2026; payment on or before December 4, 2026.
  • · Debendra Banthiya appointed as Company Secretary & Compliance Officer effective November 5, 2026.
  • · The auditor's report includes a qualified conclusion due to one unreviewed subsidiary (including its two subsidiaries) contributing ₹8,357 Lacs in revenues and ₹941 Lacs in net profit for Q2 FY27.
  • · Other income declined 3.5% YoY in H1 FY27 (₹4,145 Lacs vs ₹4,296 Lacs in H1 FY26).
  • · Group's share of net loss from associates was ₹34 Lacs for Q2 FY27 and ₹189 Lacs for H1 FY27.
  • · The company acquired IncNut Digital Private Limited (effective June 1, 2026) and Axiom Ayurveda Private Limited (effective April 1, 2026) during the current financial year.
Emami Limited Corporate Action mixed materiality 8/10

05-11-2026

Emami Limited's Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27, and declared a first interim dividend of ₹5 per share (500% on face value of ₹1) for FY 2026-27, with a record date of November 13, 2026 and payment by December 4, 2026. Consolidated revenue from operations grew 36.2% YoY to ₹1,08,765 lacs in Q2 FY27 and 24.9% YoY to ₹2,12,686 lacs in H1 FY27, while total income rose 35.5% YoY in Q2 and 24.2% YoY in H1. However, the auditor's review report is qualified due to one unreviewed subsidiary, and the company also appointed a new Company Secretary & Compliance Officer.

  • · The auditor's review report is qualified because one subsidiary (including its two subsidiaries) with total revenues of ₹8,357 lacs and net profit of ₹941 lacs for Q2 FY27 was not reviewed by any auditor.
  • · Three subsidiaries reviewed by independent auditors reported a combined net loss of ₹439 lacs for H1 FY27, despite a net profit of ₹563 lacs in Q2 FY27.
  • · One subsidiary group (including six subsidiaries) reported a net cash outflow of ₹189 lacs for H1 FY27.
  • · One subsidiary group (including one subsidiary) reported a net loss of ₹452 lacs for the period June 1 to September 30, 2026.
  • · The group's share of net loss from associates was ₹34 lacs for Q2 FY27 and ₹189 lacs for H1 FY27.
  • · The interim dividend of ₹5 per share represents a 500% payout on the face value of ₹1 per share.
  • · The record date for the interim dividend is November 13, 2026, and payment is due by December 4, 2026.
  • · Debendra Banthiya was appointed as Company Secretary & Compliance Officer and Nodal Officer effective November 5, 2026.
  • · The board meeting commenced at 12:00 PM and concluded at 1:35 PM on November 5, 2026.
Emami Limited Market Update mixed materiality 9/10

05-11-2026

Emami Limited reported consolidated revenue from operations of ₹1,08,765 Lacs for Q2 FY27, up 36.2% YoY from ₹79,851 Lacs in Q2 FY26, driven by strong domestic growth and contributions from recent acquisitions (Axiom Ayurveda and IncNut Digital). However, consolidated PAT declined 1.9% YoY to ₹14,550 Lacs from ₹14,835 Lacs, and standalone PAT fell 25.1% YoY to ₹13,646 Lacs from ₹18,234 Lacs, impacted by higher tax expenses and acquisition-related costs. The Board declared an interim dividend of 500% (₹5 per share) and completed a buyback of 73,00,000 equity shares for ₹28,124 Lacs.

  • · Consolidated revenue from operations for H1 FY27 stood at ₹2,12,686 Lacs, up 24.9% YoY from ₹1,70,260 Lacs.
  • · Consolidated PAT for H1 FY27 was ₹28,444 Lacs, down 9.0% YoY from ₹31,261 Lacs.
  • · Standalone revenue from operations for H1 FY27 was ₹1,47,812 Lacs, up 8.6% YoY from ₹1,36,093 Lacs.
  • · Standalone PAT for H1 FY27 was ₹31,868 Lacs, down 7.7% YoY from ₹34,543 Lacs.
  • · Consolidated total comprehensive income for Q2 FY27 was ₹17,125 Lacs, up 17.6% YoY from ₹14,562 Lacs.
  • · Standalone total comprehensive income for Q2 FY27 was ₹16,371 Lacs, down 8.0% YoY from ₹17,787 Lacs.
  • · Consolidated basic EPS for Q2 FY27 was ₹3.30, down from ₹3.40 in Q2 FY26.
  • · Standalone basic EPS for Q2 FY27 was ₹3.13, down from ₹4.17 in Q2 FY26.
  • · The auditor's report includes a qualified conclusion due to unreviewed financials of one subsidiary (including its two subsidiaries) with revenues of ₹8,357 Lacs for the quarter.
  • · The buyback of 73,00,000 equity shares was completed on October 9, 2026, at a total cost of ₹28,124 Lacs.
  • · Goodwill on the consolidated balance sheet increased from ₹6,819 Lacs (Mar 2026) to ₹26,261 Lacs (Sep 2026), primarily due to acquisitions.
  • · Other intangible assets rose from ₹20,681 Lacs to ₹66,462 Lacs over the same period.
  • · Consolidated net cash used in financing activities was ₹31,792 Lacs for H1 FY27, driven by buyback and debt repayment.
  • · Standalone cash and cash equivalents fell sharply from ₹13,405 Lacs (Mar 2026) to ₹682 Lacs (Sep 2026).
Dabur India Limited Analyst/Investor Meet mixed materiality 8/10

05-11-2026

Dabur India Ltd. presented its Q2 FY27 results and Vision VII strategy at an analyst meet on November 5, 2026. Consolidated revenue grew 11.6% to INR ,563 Cr and PAT grew 11.7% to INR SOS Cr, while operating profit grew 7.5% to INR632 Cr with a 60 bps margin decline. India FMCG revenue grew 10.7% with volume growth of 5.5%, but the company noted a challenging macro environment with elevated input costs and inflation pressuring gross margins. International business grew 20.0% to INR1,091 Cr, while the Healthcare segment grew only 6.9% and Home & Personal Care grew 10.9%.

  • · General Trade recorded mid to high single digit growth, while alternate channels registered strong double-digit growth.
  • · Beverage category recorded a sequential recovery with mid teens growth.
  • · Dabur has 7 #1 brands by market share: Amla (>60%), Chyawanprash (>60%), Juices & Nectar (>50%), Honey (>50%), Air Freshners (>40%), Digestives (>50%), Mosquito Repellant PAP (>60%).
  • · 50% of revenue is generated by category-defining and category-leading brands.
  • · Dabur's premium portfolio contribution reached 20% (up from 17% pre-Vision), with a target of 23% by FY28.
  • · Cost savings of 1.5x the first half of Vision VII were achieved in the second half, reinvested in brand investments.
  • · Distributor consolidation reduced stockist count by 80% to 1,629, while distributor throughput doubled and stockist attrition reduced by 43%.
  • · Dabur Ventures was launched in October 2025 with a INR 500 Cr platform for minority stakes in D2C companies.
  • · The company discontinued several products including Vedic Tea, DaburVita, Baby diapers, Adult Diapers, Dabur Red Balm, and Oliv-0-0il.
  • · DJSI updated Dabur's CSA score to 85 and ESG rating to 86.
Varun Beverages Limited Analyst/Investor Meet neutral materiality 1/10

05-11-2026

Varun Beverages Limited has informed the exchanges that its management will participate in investor meetings on November 16-17, 2026, in Mumbai, including the CITIC CLSA India Forum, JM Financial Annual India Conference, and Avendus Spark INDX conference. The company stated that no unpublished price-sensitive information will be shared during these meetings.

  • · Meetings are scheduled for November 16 and 17, 2026, in Mumbai.
  • · Three separate investor conferences are being attended: CITIC CLSA India Forum (Nov 16), JM Financial Annual India Conference (Nov 17), and Avendus Spark INDX conference (Nov 17).
  • · Management participants are Mr. Raj Gandhi and Mr. Deepak Dabas.
Dabur India Limited Analyst/Investor Meet neutral materiality 2/10

05-11-2026

Dabur India Limited has intimated to BSE and NSE under Regulation 30 of the SEBI LODR Regulations that it will participate in the CITIC CLSA India Forum investor group conference at Hotel Trident, Nariman Point, Mumbai, on Tuesday, November 17, 2026, from 11:00 A.M. to 5:00 P.M., with company officials representing it. The company states that no unpublished price sensitive information will be disclosed, and the schedule is subject to change. The filing contains no financial results, quantitative performance data, or deal terms.

  • · The conference date is listed as Tuesday, November 17, 2026, although the filing text reads 'November 29th' alongside it, an internal date inconsistency in the disclosure.
  • · Venue is Hotel Trident, Nariman Point, Mumbai; mode is physical; nature is investors group.
  • · BSE scrip code 500096 and NSE symbol DABUR.
United Spirits Limited Market Update mixed materiality 6/10

05-11-2026

United Spirits Limited disclosed an update to its October 17, 2026 intimation: the Directorate of Revenue Intelligence (DRI) has issued seizure memos under Section 110 of the Customs Act, 1962, for goods valued at approximately INR 6.45 crore, following a search conducted from October 16, 2026. The matter relates to an industry-wide customs tariff classification and preferential tariff treatment issue under the India–UK Free Trade Agreement, and the company says the industry association has received assurance from the Ministry of Commerce on an early resolution. As of now, the company reports no material impact or disruption to business, though the seizure of goods introduces uncertainty pending provisional release.

  • · Search operations were initiated under Section 105 of the Customs Act, 1962, and the company states it has furnished all documents and information sought by DRI.
  • · The company acknowledges the disclosure of the seizure memos was delayed, stating the delay was unintentional and has been promptly actioned.
  • · The company is seeking provisional release of the seized goods and says it is confident of an early resolution.
  • · The industry association discussed the matter with the Ministry of Commerce on 2 November 2026, where assurance was given on earliest resolution.
Marico Limited Analyst/Investor Meet neutral materiality 2/10

05-11-2026

Marico Limited has disclosed under Regulation 30 of the SEBI LODR Regulations that its management will attend two investor conferences: the Avendus Spark INDX One-on-One meetings on Monday, November 16, 2026 in Mumbai, and the JM Financial Annual India Conference - Group on Tuesday, November 17, 2026. The schedule is subject to change, and the company reiterated that no unpublished price sensitive information will be shared with analysts or institutional investors. The routine nature of the disclosure means no financial performance data is presented.

  • · Avendus Spark INDX One-on-One meetings scheduled for Monday, November 16, 2026 in Mumbai
  • · JM Financial Annual India Conference - Group scheduled for Tuesday, November 17, 2026
  • · Presentation materials used in these meetings are published on the company's investor website (marico.com/india/investors)
  • · Scrip Code 531642 (BSE) and Scrip Symbol MARICO (NSE)
Emami Limited Market Update neutral materiality 1/10

05-11-2026

Emami Limited has intimated the stock exchanges (NSE and BSE) under Regulation 30(5) of the SEBI Listing Regulations regarding the authorization of four Key Managerial Personnel to determine materiality of events and make disclosures to the exchanges. The authorized KMP are Shri Mohan Goenka (Vice-Chairman & Whole-time Director), Shri Harsha V. Agarwal (Vice-Chairman & Managing Director), Shri N. H. Bhansali (CEO - Finance, Strategy & Business Development and CFO), and Shri Debendra Banthiya (Company Secretary & Compliance Officer). This is a routine governance and compliance disclosure with no financial performance data.

  • · Disclosure made pursuant to Regulation 30(5) of SEBI Listing Regulations, 2015
  • · Filing signed by N. H. Bhansali (CEO - Finance, Strategy & Business Development and CFO) on November 05, 2026
  • · KMP list is also available on the Company's website at www.emamiltd.in
Emami Limited Analyst/Investor Meet neutral materiality 2/10

05-11-2026

Emami Limited filed a notice on November 5, 2026 linking to the audio recording of its conference call with analysts and investors held the same day, following the declaration of unaudited standalone and consolidated financial results for the quarter ended September 30, 2026 (Q2 FY27). The filing is an administrative disclosure under Regulation 30 of the SEBI LODR Regulations and contains no financial figures, guidance, or operational details.

  • · Conference call with analysts/investors held on November 5, 2026, after declaration of Q2 FY27 unaudited standalone and consolidated results for the quarter ended September 30, 2026
  • · Audio recording link provided via the company's investor relations page: https://www.emamiltd.in/investors/quarterly-financials/
  • · Filing made under Regulation 30 of SEBI (LODR) Regulations, 2015; NSE scrip code EMAMILTD, BSE scrip code 531162
Britannia Industries Limited Corporate Governance mixed materiality 7/10

05-11-2026

Britannia Industries reported consolidated revenue from operations of ₹5,597.79 Crore for Q2 FY27 (quarter ended 30 September 2026), up from ₹4,840.63 Crore a year earlier (roughly +15.6% YoY), and consolidated net profit after tax of ₹725.99 Crore, up from ₹655.06 Crore (roughly +10.8% YoY). Growth was not uniform: standalone profit before tax rose to ₹953.53 Crore from ₹912.75 Crore (about +4.5%), and standalone other income fell to ₹72.09 Crore from ₹110.13 Crore, which included a dividend from subsidiaries of ₹58.94 Crore in the prior-year quarter. Operating cash flow for the six months strengthened to ₹935.94 Crore from ₹369.87 Crore, but dividend payments of ₹2,172.22 Crore and a sharp rise in current borrowings (to ₹2,439.52 Crore from ₹1,071.72 Crore at 31 March 2026) warrant attention.

  • · Standalone other income fell 34.5% YoY to ₹72.09 Crore, as the prior-year quarter included ₹58.94 Crore of subsidiary dividends, so underlying operating growth is weaker than headline profit growth suggests
  • · Standalone profit before tax grew only about 4.5% YoY versus about 15.6% consolidated revenue growth
  • · Current borrowings (consolidated) rose to ₹2,439.52 Crore from ₹1,071.72 Crore at 31 March 2026, while non-current borrowings fell to ₹155.21 Crore from ₹286.11 Crore
  • · Inventories (consolidated) rose to ₹2,322.67 Crore from ₹1,345.93 Crore at 31 March 2026
  • · Dividend payments of ₹2,172.22 Crore in the six months exceeded net cash from operations of ₹935.94 Crore
  • · Share of loss in associates and joint venture was ₹(3.46) Crore for the quarter versus ₹(3.28) Crore a year earlier
Britannia Industries Limited Corporate Governance mixed materiality 7/10

05-11-2026

Britannia Industries reported unaudited consolidated revenue from operations of ₹5597.79 Crore for the quarter ended 30 September 2026, up from ₹4840.63 Crore a year earlier, and consolidated PAT of ₹725.99 Crore versus ₹655.06 Crore in the same quarter last year. For the six months, consolidated revenue from operations was ₹10597.76 Crore (vs ₹9462.85 Crore) and PAT was ₹1319.37 Crore (vs ₹1175.19 Crore). Balance-sheet borrowings rose sharply, with current borrowings of ₹2439.52 Crore against ₹1071.72 Crore at 31 March 2026, and inventories increased to ₹2322.67 Crore from ₹1345.93 Crore, while cash and cash equivalents declined to ₹190.75 Crore from ₹220.00 Crore; dividends paid over the six months totalled ₹2172.22 Crore. Other income was ₹73.51 Crore in the quarter, up from ₹52.11 Crore, but finance costs rose to ₹35.76 Crore from ₹34.68 Crore, and the share of loss of associates and joint venture widened for the six months to ₹5.25 Crore from ₹8.13 Crore only in the sense of narrowing, so the overall trend is mixed-to-positive with rising working-capital and debt pressure.

  • · Current borrowings rose to ₹2439.52 Crore from ₹1071.72 Crore at 31 March 2026, a material increase in short-term debt
  • · Inventories increased to ₹2322.67 Crore from ₹1345.93 Crore at 31 March 2026
  • · Cash and cash equivalents declined to ₹190.75 Crore from ₹220.00 Crore at 31 March 2026
  • · Net cash generated from operating activities was ₹935.94 Crore for six months versus ₹369.87 Crore a year earlier
  • · Share of loss in associates and joint venture was ₹3.46 Crore for the quarter versus ₹3.28 Crore a year earlier
Britannia Industries Limited Market Notice mixed materiality 7/10

05-11-2026

Britannia Industries reported consolidated sales of Rs 5,542 Crore for the quarter ended 30 September 2026, up 16.6% YoY, led by 13% volume growth, with net profit of Rs 726 Crore, up 10.8% YoY. For the six months ended 30 September 2026, consolidated sales reached Rs 10,506 Crore (up 13.1%, volume up 11%) and net profit reached Rs 1,319 Crore (up 12.3%). Management flagged ongoing inflationary pressures as a watch item even as momentum held.

  • · Sequential quarter-on-quarter growth was 12% in top-line and 22% in bottom-line.
  • · Bakery and adjacency portfolio and the International business registered strong acceleration, complementing Biscuit growth.
  • · Management flagged inflationary pressures as a continuing watch item.
  • · Six-month volume growth (11%) was lower than the quarterly volume growth (13%), indicating a slowdown in the earlier part of the period.
Dabur India Limited Analyst/Investor Meet neutral materiality 2/10

05-11-2026

Dabur India Limited has filed a Regulation 30 intimation with BSE and NSE providing a link to the audio recording of an Analyst/Institutional Investor Meet held on November 05, 2026. The filing is administrative in nature and does not disclose any financial results, guidance, or operational figures.

  • · Filing reference number SEC/SE/2026-27, dated November 05, 2026
  • · BSE scrip code 500096 and NSE symbol DABUR
  • · Audio recording hosted on the company's investor relations website under the Q2 FY2026-27 results section
  • · Filed pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015
United Spirits Limited Analyst/Investor Meet neutral materiality 3/10

05-11-2026

United Spirits Limited (USL) held its earnings call for Q2 FY27 (quarter and half year ended 30 September 2026) on 29 October 2026, and the transcript was made available on the company website. The filing is a regulatory disclosure under Regulation 30(6) of the SEBI LODR Regulations, providing access to the call transcript. No financial figures or performance details are included in this filing itself.

  • · Earnings call held on 29 October 2026 for Q2 FY27 (quarter and half year ended 30 September 2026).
  • · Transcript available at https://www.diageoindia.com/pdf-viewer.aspx?gid=307336661&src=%2F%7E%2Fmedia%2FFiles%2FD%2FDiageo-V2%2FDiageo-India%2Fnews-and-media%2Fpress-release%2F2026%2Fearnings-call-transcript-q2-fy27.pdf
  • · Filing made under Regulation 30(6) of SEBI LODR Regulations, 2015.
  • · Company Secretary: Pragya Kaul, Compliance Officer.

Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 18 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: BSE FMCG Sector Regulatory Filings

🇮🇳 More from India

View all →